Cigna Group $CI Shares Sold by Maj Invest Holding A S

Key Points

• Maj Invest Holding A S reduced its Cigna stake by 1% during the third quarter, selling 4,341 shares and retaining 439,652 shares valued at approximately $119.5 million. Institutional investors collectively own 86.99% of Cigna’s stock.
• Cigna exceeded quarterly expectations, reporting $7.78 in EPS on $71.56 billion in revenue, with revenue up 6.7% year over year. The company declared a $1.56-per-share quarterly dividend, equal to a 2.1% annualized yield.
• Analysts maintain a generally positive outlook, with a consensus rating of “Moderate Buy” and an average price target of $338.24, although some insiders sold shares under pre-arranged trading plans.

Maj Invest Holding A S lowered its holdings in Cigna Group (NYSE:CI - Free Report) by 1.0% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 439,652 shares of the health services provider's stock after selling 4,341 shares during the quarter. Cigna Group accounts for about 5.3% of Maj Invest Holding A S's investment portfolio, making the stock its 6th biggest position. Maj Invest Holding A S's holdings in Cigna Group were worth $119,512,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in CI. Conning Inc. boosted its stake in shares of Cigna Group by 2.0% in the 3rd quarter. Conning Inc. now owns 136,910 shares of the health services provider's stock valued at $37,216,000 after purchasing an additional 2,673 shares in the last quarter. Asset Management One Co. Ltd. grew its holdings in shares of Cigna Group by 2.4% in the 3rd quarter. Asset Management One Co. Ltd. now owns 125,024 shares of the health services provider's stock worth $33,985,000 after purchasing an additional 2,982 shares during the last quarter. Balance Wealth Partners LLC acquired a new stake in shares of Cigna Group during the 3rd quarter worth about $48,000. Roman Butler Fullerton & Co. increased its position in shares of Cigna Group by 0.6% during the 3rd quarter. Roman Butler Fullerton & Co. now owns 13,531 shares of the health services provider's stock worth $4,039,000 after purchasing an additional 76 shares in the last quarter. Finally, Independence Bank of Kentucky lifted its holdings in Cigna Group by 11.4% during the 3rd quarter. Independence Bank of Kentucky now owns 1,652 shares of the health services provider's stock valued at $449,000 after purchasing an additional 169 shares during the last quarter. Institutional investors and hedge funds own 86.99% of the company's stock.

Insider Transactions at Cigna Group

In other news, insider Nicole Jones sold 2,677 shares of the company's stock in a transaction dated Tuesday, August 18th. The stock was sold at an average price of $279.61, for a total value of $748,515.97. Following the completion of the sale, the insider directly owned 25,880 shares of the company's stock, valued at $7,236,306.80. This represents a 9.37% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of the company's stock in a transaction that occurred on Thursday, September 3rd. The shares were sold at an average price of $284.05, for a total transaction of $175,258.85. Following the completion of the sale, the insider directly owned 5,053 shares of the company's stock, valued at $1,435,304.65. The trade was a 10.88% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 22,730 shares of company stock valued at $6,293,359 in the last quarter. 0.60% of the stock is currently owned by corporate insiders.

Cigna Group Stock Down 1.2%

NYSE CI opened at $294.76 on Thursday. The stock has a fifty day moving average of $282.97 and a 200-day moving average of $281.33. The stock has a market capitalization of $77.89 billion, a P/E ratio of 12.20, a price-to-earnings-growth ratio of 1.04 and a beta of 0.29. Cigna Group has a 52 week low of $239.51 and a 52 week high of $316.27. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.76 and a current ratio of 0.76.

Cigna Group (NYSE:CI - Get Free Report) last posted its quarterly earnings results on Thursday, July 30th. The health services provider reported $7.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.60 by $0.18. Cigna Group had a return on equity of 19.75% and a net margin of 2.27%. The business had revenue of $71.56 billion for the quarter, compared to analysts' expectations of $70.14 billion. During the same quarter last year, the business earned $7.20 earnings per share. The firm's quarterly revenue was up 6.7% compared to the same quarter last year. On average, equities research analysts forecast that Cigna Group will post 30.49 EPS for the current year.

Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 17th. Investors of record on Thursday, December 3rd will be paid a dividend of $1.56 per share. The ex-dividend date of this dividend is Thursday, December 3rd. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.1%. Cigna Group's payout ratio is 25.82%.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on the stock. Royal Bank Of Canada reaffirmed an "outperform" rating and set a $337.00 price objective on shares of Cigna Group in a report on Thursday, October 1st. UBS Group reiterated a "buy" rating on shares of Cigna Group in a research note on Thursday, October 1st. Evercore started coverage on Cigna Group in a report on Wednesday, September 9th. They issued an "in-line" rating and a $290.00 target price on the stock. Jefferies Financial Group lowered Cigna Group from a "buy" rating to a "hold" rating and decreased their price target for the stock from $336.00 to $307.00 in a research report on Tuesday, August 4th. Finally, Piper Sandler reaffirmed an "overweight" rating on shares of Cigna Group in a report on Friday, October 23rd. Fifteen investment analysts have rated the stock with a Buy rating and eight have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $338.24.

More Cigna Group News

Here are the key news stories impacting Cigna Group this week:

• Positive Sentiment: Cigna declared a quarterly cash dividend of $1.56 per share, payable December 17 to shareholders of record on December 3. The payment reinforces shareholder returns and signals continued financial stability, although the unchanged dividend may already be reflected in the stock. The Cigna Group Declares Quarterly Dividend
• Positive Sentiment: Piper Sandler reiterated a $370 price target, suggesting substantial potential upside from recent trading levels and continued analyst confidence in Cigna’s valuation. Piper Sandler Reiterates $370 Target
• Neutral Sentiment: Cigna scheduled its next quarterly results for November 5. The report is likely to be the next significant catalyst, particularly for guidance, medical-cost trends, client retention and profitability. Cigna Sets November 5 Results Date
• Neutral Sentiment: Recent analysis argues that retaining clients is less important than ensuring contracts are profitable. This keeps investor focus on the quality of Cigna’s earnings and margins rather than enrollment growth alone. Client Retention Matters, But Contract Profitability Matters More
• Negative Sentiment: A newly introduced House bill would impose stricter prior-authorization deadlines, greater benefit transparency, limits on midyear coverage changes, reimbursement requirements and penalties for billing errors. Cigna could face higher administrative and compliance costs if the proposal advances, though it currently has no cosponsors and most healthcare provisions would not take effect until 2029. Ending Patient Runaround Act

About Cigna Group

The Cigna Group NYSE: CI is a global health services company that provides insurance coverage, health care benefits and related services. Its operations are primarily organized through Cigna Healthcare, which offers medical, pharmacy, dental, behavioral health and other benefit programs to employers, government organizations and individuals, primarily in the United States.

The company also operates Evernorth Health Services, a health services platform that includes pharmacy benefit management, specialty pharmacy, care management and health-care delivery capabilities.

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.